Newswire (Published: Wednesday, November 6, 2019, Received: Wednesday, November 6, 2019, 5:23:39 PM CST)

Word Count: 213

2019 NOV 06 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Data detailed on Oncology - Prostate Cancer have been presented. According to news reporting out of Oklahoma City, Oklahoma, by NewsRx editors, the research stated, “The management of high-risk prostate cancer is evolving. Currently, most decisions are based on traditional factors such as tumor grade and stage.”

Our news journalists obtained a quote from the research from the University of Oklahoma, “However, we are in a state of evolution. A new understanding of the value of both genetic and somatic germline testing is upon us.”

According to the news editors, the research concluded: “Perhaps even more exciting is the recognition that genomic testing can and should be moved up in certain high-risk patients so more effective and targeted therapy can be applied earlier in the disease state.”

For more information on this research see: Urology perspective on the expanding world of germline testing for prostate cancer. The Canadian Journal of Urology, 2019;26(5S2):5-6.

Our news journalists report that additional information may be obtained by contacting M.S. Cookson, Dept. of Urology, University of Oklahoma, Oklahoma City, Oklahoma, United States.

(Our reports deliver fact-based news of research and discoveries from around the world.)


University of Oklahoma


North America
United States
Oklahoma City


Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
            Urological Diseases
      Medical Specialties and Practices